Summary of 2025
2025 markerer et viktig jubileum for Inven2 – det er 15 år siden vi ble etablert. På disse årene har vi vært gjennom en imponerende reise sammen med forskere, gründere, investorer og mange andre partnere i og utenfor økosystemet for innovasjon. Sammen har vi bygget opp et av Norges viktigste miljøer for kommersialisering av forskning og innovasjon innen livsvitenskap og andre forskningsområder.
Gain insight into success stories and key figures.
Latest news
More news
Latest news
Here you can read the latest news regarding Inven2s portfolio businesses, innovation projects and clinical studies. Every month we write longer articles where we interview current researchers and clinicians..
Inven2 launches new marketing platform: Inven2 Marketplace
Inven2 has launched Inven2 Marketplace – a new digital platform that consolidates all our available technologies and licensing opportunities in one...
Drug Development Project from Oslo Won the Pitch Competition at The Forge
After six intensive months of development, mentoring, and investor preparation, Norway’s first national biotechnology accelerator program, The...
300.000 kroner for best Innovation
Inven2 is now collecting ideas for this year's idea competition. The winner will receive 300.000 kroner, in addition to advice and assistance in...
Events
More events
Events
There are no upcoming events at this time.
Innovation
Inven2’s core business is innovation. We contribute in the process of commersialising good ideas from talented researchers, turning them into products and services that make a difference.
Clinical studies
Inven2 work closely with hospitals and companies to make sure clinical studies are completed quick and efficient, to the best for Norwegian patients.
Key figures 2010 – 2025
# Innovations (DOFI)
# Companies established
# Licence agreements
# New patent applications
MNOK transferred back to research, innovation and inventors
# Clinical Trials managed
Portfolio businesses
More businesses
Portfolio businesses
Inven2 has a portfolio comprising 40 companies. We have established them either on our own or alongside investors and others. The point of departure for the companies are research results from innovative researchers. he portfolio value in December 2025 is NOK 4 billion, but this will vary with the value of the individual company and how long we are shareholders in the most valuable companies.
Exits
Products on the market
More products
Products on the market
Inven2 has contributed to many products and services that have served society well through licensing to industry or business start-ups within a range of technology fields. What follows is a selection of them.
MULTI-NEEDLE LANGMUIR PROBE (M-NLP)
Photo: Norsk Romsenter
EPISHUTTLE – Transport isolator
Photo: EpiGuard
QUEST 5 HMC DNA ELISA KIT Epigenetic kit
Photo: Zymo Research